Parkinson DiseaseNCT02585154
Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation
A study testing Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015), closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015) and Deep Brain Stimulation off in people with Parkinson Disease, run by University of Oxford at 2 sites in United Kingdom.
Trial summary
Parkinson's disease is a common, disabling, progressive condition characterised by severe problems with movement for which medical treatment in the longer term can be unsatisfactory. Read more about this study
- Who is it for?
- Ages 18 to 74 years
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015), closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015) and Deep Brain Stimulation off
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 2 sitesUnited Kingdom
- Study dates
- 8 Jan 2016to 31 Dec 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 74 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Study participants will be Parkinson's disease patients undergoing deep brain stimulation of the subthalamic nucleus (STN).
- Whether or not a patient is selected for deep brain stimulation surgery is determined by the patient's clinical team purely on independent clinical grounds.
- Only those patients who have been accepted for deep brain stimulation treatment by their clinical neurologist and functional neurosurgeon will be introduced to the project and have their details passed on to the research team for further information and formal consenting.
- Able to give informed consent.
Who cannot join
- Lack of capacity to consent (judged by the clinician taking consent as not having sufficient mental capacity to understand the study and its requirements). This is including anyone who, in the opinion of the clinician taking consent, is unlikely to retain sufficient mental capacity for the duration of their involvement in the study.
- Cognitive impairment/lack of capacity to perform experimental task.
Trial locations and contacts
2 sites in 1 country.
United Kingdom2 sites
University College London Hospitals NHS Trust
London, WC1N 3BG
Oxford University Hospitals NHS Trust
Oxford, OX3 9DU
About this study
Parkinson's disease is a common, disabling, progressive condition characterised by severe problems with movement for which medical treatment in the longer term can be unsatisfactory. Deep brain stimulation is a treatment, which directly stimulates the nerve cells affected inside the brain to help overcome the difficulties with movement. Classically, deep brain stimulation stimulates in a manner that is constant and independent of a patients underlying condition as reflected in their brainwave activity. Recent research has suggested that adjusting deep brain stimulation in real time using analyses of brain signals recorded from deep brain stimulation electrodes (termed closed loop deep brain stimulation) nay be better than classical deep brain stimulation in alleviating difficulties with movement. However, it remains unclear whether closed-loop deep brain stimulation also leads to fewer unwanted side effects on movement control. In order to answer this question, the investigators will analyze deep brain stimulation activity and activity recorded from the surface of the head in Parkinson's disease patients undergoing deep brain stimulation surgery. During the recordings patients will perform different movement tasks. Deep brain stimulation has been found to reduce patients' ability to suppress inappropriate movements in certain tasks and performance in these tasks will be the core point of interest. The recordings will be conducted three times: During closed loop deep brain stimulation, classical deep brain stimulation and while the stimulator is turned off. This will allow the investigators to assess putative differences in the effect of closed loop and classical deep brain stimulation with regards to wanted and unwanted effects on movement control and to elucidate their correlates in the brain.
Read the detailed description
Study Summary Patients will undergo standard 2 part deep brain stimulation implantation (electrode implantation day 1, battery and stimulator implantation approximately day 7, home approximately day 10). The experiments will be performed whilst the patients are inpatients between the two operations and will therefore not require any extra visits or delay in starting therapeutic deep brain stimulation. This paradigm is the standard method for conducting local field potential research in human and represents the paradigm by which the vast majority of previous research in this area has been conducted. Patients will be tested either at Oxford University Hospitals National Health Service Trust or University College London National Health Service Trust.
At least 24h after electrode implantation (first of the two surgeries) patients will be approached about the study and left with the patient information sheet for 24 hours, before further discussion, and, if appropriate consent.
Thereafter, the following procedures will be undertaken:
- The subjects will participate in a short assessment testing their cognitive function and fill out questionnaires regarding handedness and impulsiveness traits . Furthermore, they will be introduced to the three motor tasks, which they will perform during the definitive test. Together, these assessments will take approximately one hour. Prior to the next steps, which will be conducted on the same day or 1-3 days later(depending on the preferences of the participant), participants will be requested to withhold their usual medication overnight so that they are assessed off medication on the morning of the tests.
- Deep brain stimulation will be evaluated in order to find the best stimulation parameters ( the settings, which yield the best clinical benefit) for each individual patient. This will take approximately 1 hour and is part of the standard clinical procedure.
- Recordings will be made from the deep brain stimulation electrodes and electrodes placed on the surface of the head in order to assess activity and communication within the brain. During the recordings participants will perform three motor tasks using their hands. In the first two tasks they have to decide whether to press a button on a computer mouse or refrain from a response depending on the nature of some small dots moving in different directions on a computer screen. This will allow assessing patients' ability to perform and inhibit movements. In the third task they are asked to press a button depending on the direction of an arrow presented in the middle of the screen, while ignoring arrows around this central cue. This additional task will allow assessing patients' ability to control conflicting response tendencies. The recordings will be conducted three times: During closed loop deep brain stimulation, open loop deep brain stimulation and while the stimulator is turned off. The order of these sessions will be randomized and counter-balanced across participants. The experimental recordings will take approximately 2 hours.
Prior to recordings we will assess motor impairment using a validated clinical score and patients will have the opportunity to familiarize themselves with the motor tasks.
Completion of the recordings will mark the end of an individual's participation in the study. Given the overall duration of the study patients will be offered the opportunity to complete the recordings after overnight withdrawal of dopaminergic medication over two days or on one single day if preferred.
Thereafter the patient will have their stimulator implanted as usual (most often 7 days after the first operation) and they will be discharged on day 9 - 10 according to their clinical recovery.
For patients with already implanted pacemakers, suitable participants will be identified by the Functional Neurosurgery team who follow the clinical care of the patients. The invitation letter and information sheet will be provided by the clinical team on behalf of the researchers. If patients are interested, they would then be asked to contact the researchers. The same assessments as above (rating scales, motor tasks) will be conducted on one single day in the National Hospital for Neurology and Neurosurgery, London.
Clinical intervention:
Externalisation of electrode wires. The externalisation of the electrode wires will be performed by trained neurosurgeons. This will occur in the awake patient under local anaesthetic (or under a brief general anaesthetic if independent assessment of the patient's clinical state by an anaesthetist determines this to be necessary) in the neurosurgical department.
Research intervention:
Single blinded counterbalanced within-subject trial. Patients will undergo closed loop deep brain stimulation, open loop deep brain stimulation and a session without deep brain stimulation whilst performing motor tasks. Local field potential and electroencephalographic activity will be simultaneously recorded.
Closed loop deep brain stimulation will be delivered through a portable battery operated electronic device connected to the externalised leads. This incorporates an amplifier that allows brain waves to be recorded during deep brain stimulation, a controller and a stimulator. The controller is a simple rectifier and level detector, which then operates a switch that allows stimulation. The level detector is adjusted so that deep brain stimulation is only allowed when a certain clinician determined threshold of pathological brain wave activity is exceeded. The stimulator supplies stimulation at a frequency of 130 Hertz and a voltage as used for standard clinical stimulation. The device weighs about 350 grams and is most simply carried in a small shoulder bag, or attached to a belt.
- Conditions
- Parkinson Disease
- Being tested
- Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015), closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015), Deep Brain Stimulation off, local field potentials and electroencephalography recordings
- Keywords
- Deep Brain Stimulation
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015)Procedure or surgery
'Classical' high-frequency Deep Brain Stimulation, which is applied irrespective of ongoing brain activity.
closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015)Procedure or surgery
Deep Brain Stimulation, which is applied depending on ongoing brain activity.
Deep Brain Stimulation offProcedure or surgery
Deep Brain Stimulation is turned off.
local field potentials and electroencephalography recordingsDevice
Simultaneous recordings of local field potentials from subthalamic nucleus and electroencephalography
| Study group | Role | What they receive |
|---|---|---|
| Closed-loop Deep Brain Stimulation | Experimental | Closed-loop Deep Brain Stimulation Receives: Procedure: closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015); Device: local field potentials and electroencephalography recordings |
| Open loop Deep Brain stimulation | Active comparator | Open loop Deep Brain stimulation Receives: Procedure: Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015); Device: local field potentials and electroencephalography recordings |
| No Deep Brain Stimulation | Other | No Deep Brain Stimulation Receives: Procedure: Deep Brain Stimulation off; Device: local field potentials and electroencephalography recordings |
What is being measured
The primary outcome is the main question the study is designed to answer.
Ability to suppress inappropriate movements as measured by motor tasks (accuracy measured in %)
Measured: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.
Ability to suppress inappropriate movements as measured by motor tasks (response time measured in s)
Measured: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.
Secondary outcomes (2)
Local field potential spectra during open-loop deep brain stimulation, closed-loop deep brain stimulation and no deep brain stimulation
Estimate frequencies from 2 to 35 Hz.
Measured: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.
Connectivity between neural regions during open-loop deep brain stimulation, closed-loop deep brain stimulation and no deep brain stimulation
Estimate frequencies from 2 to 35 Hz.
Measured: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2015 (estimated)
- Study start8 Jan 2016
- Primary completion1 Jul 2017
- Study completion31 Dec 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- More trials run by University of OxfordThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- blinded cross-over study of no deep brain stimulation, conventional deep brain stimulation and adaptive deep brain stimulation
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Oxford
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02585154
- Sponsor's protocol ID
- 168287
- Status last verified
- Oct 2017
- First submitted
- 8 Oct 2015
- Last updated
- 4 May 2021
- Results posted
- No
Publications
Little S, Pogosyan A, Neal S, Zavala B, Zrinzo L, Hariz M, Foltynie T, Limousin P, Ashkan K, FitzGerald J, Green AL, Aziz TZ, Brown P. Adaptive deep brain stimulation in advanced Parkinson disease. Ann Neurol. 2013 Sep;74(3):449-57. doi: 10.1002/ana.23951. Epub 2013 Jul 12.
PubMed 23852650Little S, Beudel M, Zrinzo L, Foltynie T, Limousin P, Hariz M, Neal S, Cheeran B, Cagnan H, Gratwicke J, Aziz TZ, Pogosyan A, Brown P. Bilateral adaptive deep brain stimulation is effective in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):717-21. doi: 10.1136/jnnp-2015-310972. Epub 2015 Sep 30.
PubMed 26424898
Study at a glance
From the registry record, last updated by the sponsor on 4 May 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation
- ClinicalTrials.gov ID
- NCT02585154
- Acronym / sponsor ID
- 168287
- Conditions
- Parkinson Disease
- Keywords
- Deep Brain Stimulation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- University of OxfordUniversity, hospital or other
- Study start
- 8 Jan 2016 (actual)
- Primary completion
- 1 Jul 2017 (actual)
- Study completion
- 31 Dec 2019 (actual)
- First posted
- 23 Oct 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Parkinson's disease is a common, disabling, progressive condition characterised by severe problems with movement for which medical treatment in the longer term can be unsatisfactory. Deep brain stimulation is a treatment, which directly stimulates the nerve cells affected inside the brain to help overcome the difficulties with movement. Classically, deep brain stimulation stimulates in a manner that is constant and independent of a patients underlying condition as reflected in their brainwave activity. Recent research has suggested that adjusting deep brain stimulation in real time using analyses of brain signals recorded from deep brain stimulation electrodes (termed closed loop deep brain stimulation) nay be better than classical deep brain stimulation in alleviating difficulties with movement. However, it remains unclear whether closed-loop deep brain stimulation also leads to fewer unwanted side effects on movement control. In order to answer this question, the investigators will analyze deep brain stimulation activity and activity recorded from the surface of the head in Parkinson's disease patients undergoing deep brain stimulation surgery. During the recordings patients will perform different movement tasks. Deep brain stimulation has been found to reduce patients' ability to suppress inappropriate movements in certain tasks and performance in these tasks will be the core point of interest. The recordings will be conducted three times: During closed loop deep brain stimulation, classical deep brain stimulation and while the stimulator is turned off. This will allow the investigators to assess putative differences in the effect of closed loop and classical deep brain stimulation with regards to wanted and unwanted effects on movement control and to elucidate their correlates in the brain.
Detailed description
Study Summary Patients will undergo standard 2 part deep brain stimulation implantation (electrode implantation day 1, battery and stimulator implantation approximately day 7, home approximately day 10). The experiments will be performed whilst the patients are inpatients between the two operations and will therefore not require any extra visits or delay in starting therapeutic deep brain stimulation. This paradigm is the standard method for conducting local field potential research in human and represents the paradigm by which the vast majority of previous research in this area has been conducted. Patients will be tested either at Oxford University Hospitals National Health Service Trust or University College London National Health Service Trust.
At least 24h after electrode implantation (first of the two surgeries) patients will be approached about the study and left with the patient information sheet for 24 hours, before further discussion, and, if appropriate consent.
Thereafter, the following procedures will be undertaken:
- The subjects will participate in a short assessment testing their cognitive function and fill out questionnaires regarding handedness and impulsiveness traits . Furthermore, they will be introduced to the three motor tasks, which they will perform during the definitive test. Together, these assessments will take approximately one hour. Prior to the next steps, which will be conducted on the same day or 1-3 days later(depending on the preferences of the participant), participants will be requested to withhold their usual medication overnight so that they are assessed off medication on the morning of the tests.
- Deep brain stimulation will be evaluated in order to find the best stimulation parameters ( the settings, which yield the best clinical benefit) for each individual patient. This will take approximately 1 hour and is part of the standard clinical procedure.
- Recordings will be made from the deep brain stimulation electrodes and electrodes placed on the surface of the head in order to assess activity and communication within the brain. During the recordings participants will perform three motor tasks using their hands. In the first two tasks they have to decide whether to press a button on a computer mouse or refrain from a response depending on the nature of some small dots moving in different directions on a computer screen. This will allow assessing patients' ability to perform and inhibit movements. In the third task they are asked to press a button depending on the direction of an arrow presented in the middle of the screen, while ignoring arrows around this central cue. This additional task will allow assessing patients' ability to control conflicting response tendencies. The recordings will be conducted three times: During closed loop deep brain stimulation, open loop deep brain stimulation and while the stimulator is turned off. The order of these sessions will be randomized and counter-balanced across participants. The experimental recordings will take approximately 2 hours.
Prior to recordings we will assess motor impairment using a validated clinical score and patients will have the opportunity to familiarize themselves with the motor tasks.
Completion of the recordings will mark the end of an individual's participation in the study. Given the overall duration of the study patients will be offered the opportunity to complete the recordings after overnight withdrawal of dopaminergic medication over two days or on one single day if preferred.
Thereafter the patient will have their stimulator implanted as usual (most often 7 days after the first operation) and they will be discharged on day 9 - 10 according to their clinical recovery.
For patients with already implanted pacemakers, suitable participants will be identified by the Functional Neurosurgery team who follow the clinical care of the patients. The invitation letter and information sheet will be provided by the clinical team on behalf of the researchers. If patients are interested, they would then be asked to contact the researchers. The same assessments as above (rating scales, motor tasks) will be conducted on one single day in the National Hospital for Neurology and Neurosurgery, London.
Clinical intervention:
Externalisation of electrode wires. The externalisation of the electrode wires will be performed by trained neurosurgeons. This will occur in the awake patient under local anaesthetic (or under a brief general anaesthetic if independent assessment of the patient's clinical state by an anaesthetist determines this to be necessary) in the neurosurgical department.
Research intervention:
Single blinded counterbalanced within-subject trial. Patients will undergo closed loop deep brain stimulation, open loop deep brain stimulation and a session without deep brain stimulation whilst performing motor tasks. Local field potential and electroencephalographic activity will be simultaneously recorded.
Closed loop deep brain stimulation will be delivered through a portable battery operated electronic device connected to the externalised leads. This incorporates an amplifier that allows brain waves to be recorded during deep brain stimulation, a controller and a stimulator. The controller is a simple rectifier and level detector, which then operates a switch that allows stimulation. The level detector is adjusted so that deep brain stimulation is only allowed when a certain clinician determined threshold of pathological brain wave activity is exceeded. The stimulator supplies stimulation at a frequency of 130 Hertz and a voltage as used for standard clinical stimulation. The device weighs about 350 grams and is most simply carried in a small shoulder bag, or attached to a belt.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
- Model description
- blinded cross-over study of no deep brain stimulation, conventional deep brain stimulation and adaptive deep brain stimulation
| Arm | Type | Receives |
|---|---|---|
| Closed-loop Deep Brain Stimulation | Experimental | Procedure: closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015), Device: local field potentials and electroencephalography recordingsClosed-loop Deep Brain Stimulation |
| Open loop Deep Brain stimulation | Active comparator | Procedure: Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015), Device: local field potentials and electroencephalography recordingsOpen loop Deep Brain stimulation |
| No Deep Brain Stimulation | Other | Procedure: Deep Brain Stimulation off, Device: local field potentials and electroencephalography recordingsNo Deep Brain Stimulation |
Who may qualify
- Ages
- 18 to 74 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Study participants will be Parkinson's disease patients undergoing deep brain stimulation of the subthalamic nucleus (STN).
- Able to give informed consent.
Key exclusion criteria (2 listed)
- Lack of capacity to consent (judged by the clinician taking consent as not having sufficient mental capacity to understand the study and its requirements). This is including anyone who, in the opinion of the clinician taking consent, is unlikely to retain sufficient mental capacity for the duration of their involvement in the study.
- Cognitive impairment/lack of capacity to perform experimental task.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015)'Classical' high-frequency Deep Brain Stimulation, which is applied irrespective of ongoing brain activity. | Procedure or surgery | Open loop Deep Brain stimulation |
| closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015)Deep Brain Stimulation, which is applied depending on ongoing brain activity. | Procedure or surgery | Closed-loop Deep Brain Stimulation |
| Deep Brain Stimulation offDeep Brain Stimulation is turned off. | Procedure or surgery | No Deep Brain Stimulation |
| local field potentials and electroencephalography recordingsSimultaneous recordings of local field potentials from subthalamic nucleus and electroencephalography | Device | Closed-loop Deep Brain Stimulation, No Deep Brain Stimulation, Open loop Deep Brain stimulation |
Primary outcome
Ability to suppress inappropriate movements as measured by motor tasks (accuracy measured in %)
Time frame: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.
Ability to suppress inappropriate movements as measured by motor tasks (response time measured in s)
Time frame: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.
2 secondary outcomes
Local field potential spectra during open-loop deep brain stimulation, closed-loop deep brain stimulation and no deep brain stimulation
Time frame: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.
Connectivity between neural regions during open-loop deep brain stimulation, closed-loop deep brain stimulation and no deep brain stimulation
Time frame: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 May 2021.
- Background: PubMed 23852650Little S, Pogosyan A, Neal S, Zavala B, Zrinzo L, Hariz M, Foltynie T, Limousin P, Ashkan K, FitzGerald J, Green AL, Aziz TZ, Brown P. Adaptive deep brain stimulation in advanced Parkinson disease. Ann Neurol. 2013 Sep;74(3):449-57. doi: 10.1002/ana.23951. Epub 2013 Jul 12.
- Background: PubMed 26424898Little S, Beudel M, Zrinzo L, Foltynie T, Limousin P, Hariz M, Neal S, Cheeran B, Cagnan H, Gratwicke J, Aziz TZ, Pogosyan A, Brown P. Bilateral adaptive deep brain stimulation is effective in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):717-21. doi: 10.1136/jnnp-2015-310972. Epub 2015 Sep 30.
Related trials for Parkinson Disease
Not yet recruitingPhase 4
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
Overactive Bladder, Parkinson Disease
RecruitingPhase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
RecruitingObservational study
Parkinson's Disease in Type 1 Gaucher Disease
Parkinson Disease (PD), Type 1 Gaucher Disease
RecruitingPhase 2
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Carcinoma, Non-Small-Cell Lung
RecruitingPhase 2
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015), closed-loop Deep Brain Stimulation applied through custom built external stimulator (Little et al., 2013, 2015) and Deep Brain Stimulation off in people with Parkinson Disease, run by University of Oxford at 2 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 May 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Ability to suppress inappropriate movements as measured by motor tasks (accuracy measured in %) (time frame: Outcome will be assessed on day of experimental sessions (interventions), i.e. the time frame corresponds to the study duration.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02585154, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2021.